Skip to content

Guardant Health GH Enterprise value

Enterprise value at other companies

Illumina logo
IlluminaILMN
$19.8B+46.0%
Natera, Inc. logo
Natera, Inc.NTRA
$27.5B+49.9%
Quest Diagnostics logo
Quest DiagnosticsDGX
$27.54B+9.5%
Agilent Technologies logo
Agilent TechnologiesA
$34.39B+5.1%
Labcorp Holdings logo
Labcorp HoldingsLH
$28.24B+10.2%
Abbott logo
AbbottABT
$205.65B-13.1%

Other financials

Income statement

See full
Revenue$301.7M+48.3%
Gross profit$196.7M+52.8%
Operating income-$121.4M-9.3%
Net income-$112.1M-17.8%
EPS (diluted)-$0.85-10.4%

Balance sheet

See full
Cash & equivalents$1.1B+37.0%
Total debt$1.7B+30.5%
Total equity-$181.1M+27.8%
Total assets$1.9B+42.5%

Cash flow

See full
Operating cash flow-$65.6M-4.7%
CapEx$5.6M+25.1%
Free cash flow-$71.2M-6.0%

Valuation

See full
Market cap$17.12B+130%
P/S15.9×+6.3×

Profitability

See full
Gross margin64.9%+3.6pp
Operating margin-41.4%-9.4pp
Net margin-40.1%-8.1pp

Returns & leverage

See full
Return on equity-438.1%-1,655pp
Debt / equity
Current ratio4.7×+0.6×

Where this comes from

Calculated from Guardant Health’s reported figures.

The official record: Guardant Health’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Guardant Health's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Guardant Health's enterprise value?
Guardant Health (GH) reported enterprise value of $12.72B in Q1 2026.
How has Guardant Health's enterprise value changed year-over-year?
Guardant Health's enterprise value increased by 120.8% year-over-year, from $5.76B to $12.72B.
What is the long-term trend for Guardant Health's enterprise value?
Over 4 years (2021 to 2025), Guardant Health's enterprise value has grown at a -7.7% compound annual growth rate (CAGR), from $48.79B to $35.47B.
What does enterprise value mean?
What it would cost to buy the entire business, debt included and cash netted out.
How do you interpret enterprise value?
The capital-structure-neutral valuation base — used in EV/EBITDA and EV/Sales to compare companies with different leverage on a like-for-like footing.
How does enterprise value compare across companies?
Comparable across non-financial companies via the EV multiples it feeds; not used for banks and insurers.